Table 3.
Survivors (n = 44) | Non-survivors (n = 19) | ||||
---|---|---|---|---|---|
Metabolite | ppm | Mean ± SE | p-value | Mean ± SE | p-value |
Lactate | 4.08-4.13 | 2.8 ± 15.3 | 0.815 | 97.1 ± 26.4 | 0.004** |
Glycine | 3.54-3.56 | -19.6 ± 8.0 | 0.047* | 0.8 ± 14.3 | 0.601 |
GPC | 3.22-3.24 | -59.6 ± 14.6 | < 0.001** | -11.8 ± 15.7 | 0.469 |
PC | 3.21-3.22 | -95.4 ± 24.3 | < 0.001** | -67.4 ± 44.2 | 0.227 |
Cho | 3.20-3.21 | -16.6 ± 6.3 | 0.013* | -17.8 ± 6.3 | 0.084 |
tCho | 3.20-3.24 | -167.2 ± 36.7 | < 0.001** | -95.3 ± 57.5 | 0.091 |
Taurine | 3.40-3.43 | -0.8 ± 13.2 | 0.861 | 6.9 ± 12.5 | 0.398 |
β-Glucose | 4.61-4.64 | 17.8 ± 5.1 | 0.002** | -0.2 ± 8.8 | 0.841 |
The values (post- minus pre-treatment) of relative intensities are integrated peak areas from spectra normalized to equal total areas. Wilcoxon sign rank tests were used for paired statistical analyses. *p < 0.05, ** p < 0.01